Form 4 for FWONA Liberty Media Corp

Accepted 2023-07-20 00:00:00 ET · period of report 2023-07-18 · accession 0001225208-23-007606 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2023-07-20	2023-07-18	FWONA	DEEVY BRIAN	Dir	J - Other	$0.00	-3,267	0	-100%	$0
DM	2023-07-20	2023-07-18	FWONA	DEEVY BRIAN	Dir	J - Other	—	-2,973	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Series A Liberty Braves Common Stock	2023-07-18	J	D	1,000	$0.00	D	—	—	(F1) On July 18, 2023, Liberty Media Corporation (the "Issuer") redeemed (the "Redemption") each share of its Liberty Braves common stock for shares of common stock of Atlanta Braves Holdings, Inc. ("Atlanta Braves Holdings"). In the Redemption, the Issuer redeemed (i) each outstanding share of its Series A Liberty Braves common stock for one share of Atlanta Braves Holdings' Series A common stock, (ii) each outstanding share of its Series B Liberty Braves common stock for one share of Atlanta Braves Holdings' Series B common stock and (iii) each outstanding share of its Series C Liberty Braves common stock for one share of Atlanta Braves Holdings' Series C common stock. Such transactions were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
2	Common	Series C Liberty Braves Common Stock	2023-07-18	J	D	2,267	$0.00	D	—	—	(F1) On July 18, 2023, Liberty Media Corporation (the "Issuer") redeemed (the "Redemption") each share of its Liberty Braves common stock for shares of common stock of Atlanta Braves Holdings, Inc. ("Atlanta Braves Holdings"). In the Redemption, the Issuer redeemed (i) each outstanding share of its Series A Liberty Braves common stock for one share of Atlanta Braves Holdings' Series A common stock, (ii) each outstanding share of its Series B Liberty Braves common stock for one share of Atlanta Braves Holdings' Series B common stock and (iii) each outstanding share of its Series C Liberty Braves common stock for one share of Atlanta Braves Holdings' Series C common stock. Such transactions were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
3	Derivative	Restricted Stock Units-BATRK	2023-07-18	J	D	120	—	D	— · 2023-12-08 to 2023-12-08	120 Series C Liberty Braves Common Stock	(F2) In connection with the Redemption, all equity awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisionsof the incentive plan under which the equity awards were granted, such that each Braves Award was exchanged for an option to purchase, or a restricted stock unit with respect to, an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. (F3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Series C Liberty Braves common stock.
4	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	888	—	D	$25.46 · 2019-12-06 to 2025-12-06	888 Series C Liberty Braves Common Stock	(F2) In connection with the Redemption, all equity awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisionsof the incentive plan under which the equity awards were granted, such that each Braves Award was exchanged for an option to purchase, or a restricted stock unit with respect to, an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
5	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	298	—	D	$27.89 · 2022-12-06 to 2028-12-06	298 Series C Liberty Braves Common Stock	(F2) In connection with the Redemption, all equity awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisionsof the incentive plan under which the equity awards were granted, such that each Braves Award was exchanged for an option to purchase, or a restricted stock unit with respect to, an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
6	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	315	—	D	$32.76 · 2023-12-08 to 2029-12-08	315 Series C Liberty Braves Common Stock	(F2) In connection with the Redemption, all equity awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisionsof the incentive plan under which the equity awards were granted, such that each Braves Award was exchanged for an option to purchase, or a restricted stock unit with respect to, an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
7	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	490	—	D	$28.72 · 2020-12-09 to 2026-12-09	490 Series C Liberty Braves Common Stock	(F2) In connection with the Redemption, all equity awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisionsof the incentive plan under which the equity awards were granted, such that each Braves Award was exchanged for an option to purchase, or a restricted stock unit with respect to, an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
8	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	396	—	D	$26.36 · 2021-12-10 to 2027-12-10	396 Series C Liberty Braves Common Stock	(F2) In connection with the Redemption, all equity awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisionsof the incentive plan under which the equity awards were granted, such that each Braves Award was exchanged for an option to purchase, or a restricted stock unit with respect to, an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
9	Derivative	Stock Option (Right to Buy) - BATRK	2023-07-18	J	D	466	—	D	$22.56 · 2018-12-12 to 2024-12-12	466 Series C Liberty Braves Common Stock	(F2) In connection with the Redemption, all equity awards held by the reporting person with respect to the Issuer's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisionsof the incentive plan under which the equity awards were granted, such that each Braves Award was exchanged for an option to purchase, or a restricted stock unit with respect to, an equivalent number of shares of the corresponding series of Atlanta Braves Holdings' common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.